These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2962590)

  • 21. Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction.
    Dieterich DT; Poles MA; Dicker M; Tepper R; Lew E
    Am J Gastroenterol; 1993 Apr; 88(4):542-8. PubMed ID: 8385880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis.
    Reddy MM; Grieco MH; McKinley GF; Causey DM; van der Horst CM; Parenti DM; Hooton TM; Davis RB; Jacobson MA
    J Infect Dis; 1992 Sep; 166(3):607-10. PubMed ID: 1323624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Jacobson MA; O'Donnell JJ; Mills J
    Antimicrob Agents Chemother; 1989 May; 33(5):736-41. PubMed ID: 2546490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
    Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.
    Katlama C; Dohin E; Caumes E; Cochereau-Massin I; Brancon C; Robinet M; Rogeaux O; Dahan R; Gentilini M
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S18-24. PubMed ID: 1318363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity.
    Gordon M; Deeks S; De Marzo C; Goodgame J; Guralnik M; Lang W; Mimura T; Pearce D; Kaneko Y
    J Med; 1997; 28(1-2):108-28. PubMed ID: 9249617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistance.
    Canestri A; Ghosn J; Wirden M; Marguet F; Ktorza N; Boubezari I; Dominguez S; Bossi P; Caumes E; Calvez V; Katlama C
    Antivir Ther; 2006; 11(5):561-6. PubMed ID: 16964823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of human immunodeficiency virus infections.
    Pomerantz RJ; Schooley RT
    Clin Lab Med; 1987 Dec; 7(4):793-813. PubMed ID: 2446817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    Lawee D; Rosenthal D; Aoki FY; Portnoy J
    CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
    Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
    East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
    Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
    Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of viremia in human immunodeficiency virus-infected patients with renal disease.
    Kimmel PL; VedBrat SS; Pierce PF; Umana WO; Shepherd L; Verme DA; Hirsch RP; Hellman KB
    Arch Intern Med; 1995 Aug 7-21; 155(15):1578-84. PubMed ID: 7618979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
    Tamarit A; Alberola J; Mir A; Benet I; Mira JV; Muñoz C; Galindo MJ; Navarro D
    J Clin Virol; 2004 Apr; 29(4):308-14. PubMed ID: 15018860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of cytomegalovirus infections in immunosuppressed patients].
    Michon C; Girard PM; Ngovan P; Simonpoli AM; Le Hoang P
    Ann Med Interne (Paris); 1988; 139(7):511-5. PubMed ID: 2854380
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of acquired immune deficiency syndrome (AIDS)-related pneumonitis with foscarnet: a double-blind placebo controlled study.
    Youle M; Chanas A; Gazzard B
    J Infect; 1990 Jan; 20(1):41-50. PubMed ID: 2153728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foscarnet treatment in various cytomegalovirus infections.
    Brockmeyer NH; Hengge UR; Mertins L; Malessa R; Steinmetz R; Gooss M
    Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):204-7. PubMed ID: 8388868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
    Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
    J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.